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Correlation table
Correlation factor (r)
End sistolic EFT - GS r¼0.387
End diastolic EFT - GS r¼0.438
End sistolic EFT - GS6M r¼0.406
End diastolic EFT - GS6M r¼0.455
End sistolic EFT - SYNTAX score r¼0.243
End diastolic EFT - SYNTAX score r¼0.202
GS; GRACE score in hospital, GS-6M; GRACE score for six months. EFT; Epicardial fat
thickness,
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Increased Plasma hsCRP and MPO Levels may Predict Ischemia During MPI in
Slow Coronary Flow
Mustafa Yurtdas¸1, Yalin Tolga Yaylali2, Mahmut Özdemir3, Yüksel Kaya4,
Can Baba Arin1
1Van Region Training and Research Hospital, Department of Cardiology, Van,
2University of Pamukkale, School Of Medicine, Department of Cardiology, Denizli,
3University of Yüzüncü Yıl, School of Medicine, Department of Cardiology, Van,
4University of Kafkas, School of Medicine, Department of Cardiology, Kars
Objectıve: It is unclear whether changes in plasma levels of inﬂammatory markers
could explain the link between ischemia and slow coronary ﬂow (SCF). We aimed to
evaluate the plasma levels of high-sensitivity C-reactive protein (hsCRP), interleukin
(IL)-6, and myeloperoxidase (MPO) during myocardial perfusion imaging (MPI) in
SCF patients.
Methods: Study population consisted of 53 SCF patients and 30 controls. Coronary
ﬂow rates were documented by TIMI frame count (TFC). Plasma levels of hsCRP, IL-
6, MPO, and MPI were obtained in all participants.
Results: The hsCRP, IL-6 and MPO levels of SCF patients were higher than controls
(hsCRP: 4.7  2.5 vs. 1.7  1.1 mg/L, p<0.001; IL-6: 8.2  4.3 vs. 5.2  2.1 pg/mL,
p<0.001; and MPO: 75.9  59.6 vs. 24.3  16.7 ng/mL, p<0.001). Twenty-one SCF
patients exhibited myocardial perfusion defect (MPD) on MPI. In SCF patients, the
highest hsCRP, IL-6 and MPO were observed in patients with both MPD and three-
vessel slow ﬂow. Mean TFCs were positively correlated with plasma levels of hsCRP
(r¼0.424, p¼0.002), IL-6 (r¼0.367, p¼0.007), MPO (r¼0.430, p¼0.001), and
reversibility score (r¼0.671, p<0.001) in SCF patients. HsCRP and MPO were the
independent variables, which predicted positive MPI-results (hsCRP: OR, 2.176; 95%
CI, 1.200 to 3.943; p¼0.010, MPO: OR, 1.026; 95% CI, 1.007 to 1.046; p¼0.008).
Conclusıon: Inﬂammation might play a crucial role in both the pathogenesis and
development of ischemia in SCF. Association of increased levels of inﬂammatory
markers and ischemia suggests that endothelial inﬂammation might be largely
responsible for clinical presentation. New combined treatment regimens should target
at endothelial activation and inﬂammation in SCF.
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Aım: QT dispersion (QTd) is a measure of inhomogeneity of myocardial repolari-
zation, increases following impaired myocardial perfusion and its prolongation may
provide a suitable substrate for life-threatening ventricular arrhythmias. We investi-
gated the changes in QTd and heart rate variability (HRV) parameters after successful
coronary artery revascularization in patient with chronic total occlusions (CTO).
Methods: One hundred and thirty nine successfully revascularized CTO patients were
included in this study (118 men, 21 women, mean age 58.39.6 years). QTd was
measured from a 12-lead electrocardiogram and QTd was deﬁned as the difference
between maximum and minimum QT interval. HRV analyses of all subjects were
obtained. Frequency domain (LF:HF) and time domain (SDNN, pNN50 and rMSSD)
parameters were analyzed. QT intervals were also corrected for heart rate using the
Bazett's formula, and the corrected QT interval dispersion (QTcd) was then calculated.
All measurements were made before and after percutaneous coronary intervention
(PCI).
Results: Both QTd and QTcd showed signiﬁcant improvement following successfully
revascularization of CTO (55.8314.79 to 38.8711.69; p<0.001 and 61.0216.28
to 42.9213.41; p<0.001). The revascularization of LAD (n¼38), Cx (n¼28) and
RCA (n¼73) resulted in decrease in HRV indices including SDDN, rMSSD and
pNN50, however none of the variables reached statistical signiﬁcance.
Conclusıon: Successful revascularization of CTO may result in improvement in
regional heterogeneity of myocardial repolarization, evidenced as decreased QTcd
after the PCI. The revascularization in CTO lesions does not seem to have a signiﬁcant
impact on HRV.C200 JACC VoPP-296
Evaluation of Diagnostic Value of Serum Vitronectin Level in Patient with Acute
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Introductıon: Vitronectin (VN), a 459 aminoacid long glycoprotein with a mass of 75
kDa, is found in plasma, extracellular matrix (ECM) and a granules of platelets. VN
functions as a regulator of platelet adhesion and aggregation, coagulation and ﬁbri-
nolysis. Plasma VN levels were found to be elevated in patients with coronary artery
disease (CAD), and a positive correlation between VN levels and CAD severity has
been demonstrated. VN was also shown to be an independent predictor of adverse
cardiovascular outcomes following acute stenting in patients with acute coronary
syndromes (ACS) or stable angina.
The aim of this study was to investigate the diagnostic role of serum VN level at
admission in patients with ACS. The relation between extent of CAD and VN levels
was also investigated.
Methods: Sixty-two patients (40 men, mean age 59.910.3 years and 22 women,
mean age 68.911.2 years), who had been admitted to coronary care unit with ﬁrst
time diagnosis of ACS (ST elevation myocardial infarction [STEMI], non-ST eleva-
tion myocardial infarction [NSTEMI]) were consecutively included in the study.The
control group consisted of 18 stable patients in whom normal coronary arteries were
documented in coronary angiography. Patients were divided into two sub-groups as
STEMI and NSTEMI. Blood samples were drawn within 6 hours after onset of chest
pain and serum VN, high sensitive C-reactive protein (hs-CRP) and N-terminal pro-
brain natriuretic peptide (NT-proBNP) levels were measured using an enzyme
immunoassay method. Also, TIMI and GRACE clinical risk scores were calculated on
admission for all ACS patients. Appropriate statistical methods were utilized to
evaluate the diagnostic value of VN in ACS.
Results: The VN serum levels were demonstrated to be higher in MI patients
(7.0011.94 mg/ml in STEMI group, 7.7218.02 mg/ml in NSTEMI group vs.
1.812.22 mg/ml in controls, p¼0.012). When VN levels were compared between
STEMI and NSTEMI groups, no signiﬁcant differences were observed (p¼0.41).
Also, there was a signiﬁcant positive correlation between VN levels and Gensini score
only in NSTEMI patients (r¼0.436, p¼0.013). When the diagnostic value of VN
levels for MI was investigated, a cut-off value of 1.59 mg/ml yielded a sensitivity of
64%, a speciﬁcity of 84%, a positive predictive value of 93%, and a negative
predictive value of 41%. Also, when the diagnostic utility of VN was assessed using
ROC analysis, an area under the curve (AUC) of 0.72 was found (95% CI: 0.60-0.84;
p¼0.004; Figure).
Conclusıon: The present study demonstrate that, VN may have a utility as a diag-
nostic marker in patients with ACS. Also, VN may have a role to predict extension
and severity of CAD in patients with NSTEMI.PP-297
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Aım: Angiopoietin-like protein-6 (Angptl6) is a growth factor which enhances the
survival of hematopoietic stem cells. It is hypothesized that it may exert an anti-
atherosclerotic effect through enhanced survival of endothelial progenitor cells. Thel 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
